title: Drotrecogin alfa (activated) should not be used in patients with severe sepsis and low risk for death.
authors.affiliation: Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
authors.forename: Sanjay
authors.initials: S
authors.lastname: Gupta
authors.forename: Eric B
authors.initials: EB
authors.lastname: Milbrandt
authors.forename: Lakshmipathi
authors.initials: L
authors.lastname: Chelluri